Patents by Inventor Yingsheng Zhang

Yingsheng Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Azole derivatives and pharmaceutical compositions containing them
    Patent number: 7541375
    Abstract: The invention provides substituted pyrazolidinone compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing various cancers, inflammation, septic shock, preterm labor, infertility, pain, and ischemia, and other diseases and disorders associated with MEK-1 and/or ERK-2 activation.
    Type: Grant
    Filed: July 24, 2007
    Date of Patent: June 2, 2009
    Assignee: Laboratoires Serono SA
    Inventors: Stephen J. Arkinstall, Antonio Arulanandam, Xuliang Jiang, Sharad Magar, Roustem Nabioullin, John Yingsheng Zhang, Peter Blume-Jensen
  • Azole derivatives and pharmaceutical compositions containing them
    Patent number: 7253199
    Abstract: The invention provides substituted pyrazolidinone compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing various cancers, inflammation, septic shock, preterm labor, infertility, pain, and ischemia, and other diseases and disorders associated with MEK-1 and/or ERK-2 activation.
    Type: Grant
    Filed: October 23, 2002
    Date of Patent: August 7, 2007
    Assignee: Applied Research Systems ARS Holding N.V.
    Inventors: Stephen J. Arkinstall, Antonio Arulanandam, Xuliang Jiang, Sharad Magar, Roustem Nabioullin, John Yingsheng Zhang, Peter Blume-Jensen
  • Matrix metalloproteinase inhibitors and method of using same
    Patent number: 6531499
    Abstract: Peptoid compounds of Formula I and Formula II are disclosed The compounds are useful in the treatment of matrix metalloproteinase-mediated disorders.
    Type: Grant
    Filed: July 23, 2001
    Date of Patent: March 11, 2003
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Donald T. Witiak, Paul J. Bertics, Yingsheng Zhang
  • Matrix metalloproteinase inhibitors and method of using same
    Publication number: 20020032347
    Abstract: Peptiod compounds of Formula I and Formula II are disclosed 1
    Type: Application
    Filed: July 23, 2001
    Publication date: March 14, 2002
    Inventors: Donald T. Witiak, Deanne B. Witiak, Paul J. Bertics, Yingsheng Zhang
  • Matrix metalloproteinase inhibitors and method of using same
    Patent number: 6294694
    Abstract: Peptoid compounds of Formula I and Formula II are disclosed The compounds are useful in the treatment of matrix metalloproteinase-mediated disorders.
    Type: Grant
    Filed: June 4, 1999
    Date of Patent: September 25, 2001
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Donald T. Witiak, Paul J. Bertics, Yingsheng Zhang